Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)

HKD 1.3

(-2.99%)

Total Liabilities Summary of Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd.'s latest annual total liabilities in 2023 was 387.11 Million CNY , up 32.52% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd.'s latest quarterly total liabilities in 2024 Q1 was 406.21 Million CNY , up 4.94% from previous quarter.
Jacobio Pharmaceuticals Group Co., Ltd. reported annual total liabilities of 292.12 Million CNY in 2022, up 244.7% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd. reported annual total liabilities of 84.74 Million CNY in 2021, up 4.43% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd. reported quarterly total liabilities of 406.21 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Jacobio Pharmaceuticals Group Co., Ltd. reported quarterly total liabilities of 332.27 Million CNY for 2023 Q1, up 13.74% from previous quarter.

Annual Total Liabilities Chart of Jacobio Pharmaceuticals Group Co., Ltd. (2023 - 2018)

Historical Annual Total Liabilities of Jacobio Pharmaceuticals Group Co., Ltd. (2023 - 2018)

Year	Total Liabilities	Total Liabilities Growth
2023	387.11 Million CNY	32.52%
2022	292.12 Million CNY	244.7%
2021	84.74 Million CNY	4.43%
2020	81.15 Million CNY	-90.26%
2019	833.4 Million CNY	46.0%
2018	570.84 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	406.21 Million CNY	4.94%
2024 Q2	406.21 Million CNY	0.0%
2023 Q1	332.27 Million CNY	13.74%
2023 FY	387.11 Million CNY	32.52%
2023 Q4	387.11 Million CNY	0.0%
2023 Q3	387.11 Million CNY	16.5%
2023 Q2	332.27 Million CNY	0.0%
2022 Q3	292.12 Million CNY	242.37%
2022 Q2	85.32 Million CNY	0.0%
2022 Q1	85.32 Million CNY	0.68%
2022 FY	292.12 Million CNY	244.7%
2022 Q4	292.12 Million CNY	0.0%
2021 Q3	84.74 Million CNY	6.48%
2021 Q4	84.74 Million CNY	0.0%
2021 Q1	79.58 Million CNY	-1.92%
2021 FY	84.74 Million CNY	4.43%
2021 Q2	79.58 Million CNY	0.0%
2020 FY	81.15 Million CNY	-90.26%
2020 Q4	81.15 Million CNY	0.0%
2020 Q3	81.15 Million CNY	-95.33%
2020 Q2	1.73 Billion CNY	0.0%
2020 Q1	1.73 Billion CNY	108.65%
2019 FY	833.4 Million CNY	46.0%
2019 Q1	- CNY	0.0%
2019 Q3	833.4 Million CNY	0.0%
2019 Q4	833.4 Million CNY	0.0%
2018 FY	570.84 Million CNY	0.0%

Peer Total Liabilities Comparison of Jacobio Pharmaceuticals Group Co., Ltd.

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-153.314%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	94.515%